Interrogating therapy response and resistance in engineered preclinical models.

被引：0
|
作者：
Dow, Lukas E. [1 ]
机构：
[1] Weill Cornell Med, New York, NY USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA24
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] Preclinical testing using tumors from genetically engineered mouse mammary models.
    Varticovski, L.
    Hollingshead, M. G.
    Anver, M. R.
    Robles, A. I.
    Green, J. E.
    Hunter, K. W.
    Merlino, G.
    Nunez, N.
    Hursting, S. D.
    Steeg, P. S.
    Barrett, C. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 557S - 557S
  • [2] Interrogating gene expression programs from preclinical analyses of genetically engineered mouse models
    Abate-Shen, Cory
    Meneses, Alvaro Aytes
    Kinkade, Carolyn W.
    Mitrofanova, Antonina
    Lefebvre, Celine
    Chua, Chee Wai
    Castillo-Martin, Mireia
    Gelmann, Edward
    Shen, Michael M.
    Califano, Andrea
    [J]. CANCER RESEARCH, 2011, 71
  • [3] Telotristat ethyl to enhance cytotoxic chemotherapy response in preclinical cholangiocarcinoma models.
    Awasthi, Niranjan
    Schwarz, Margaret
    Schwarz, Roderich E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [4] PRECLINICAL MODELS OF CELLULAR THERAPY: INFLAMMATORY RESPONSE
    Dash, Pramod
    [J]. JOURNAL OF NEUROTRAUMA, 2015, 32 (12) : A139 - A139
  • [5] Synergistic drug combinations prevent drug resistance in anaplastic large cell lymphoma preclinical models.
    Sharma, Geeta G.
    Arosio, Giulia
    Villa, Matteo
    Mauri, Mario
    Zappa, Marina
    Magistroni, Vera
    Ceccon, Monica
    Redaelli, Sara
    Crespiatico, Ilaria
    Fontana, Diletta
    Mastini, Cristina
    Garbin, Anna
    Lovisa, Federica
    Mussolin, Lara
    Piazza, Rocco
    Gambacorrti-Passerini, Carlo
    Mologni, Luca
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [6] Genetic dissection of breast cancer development and therapy resistance in mouse models.
    Jonkers, Jos
    [J]. CANCER RESEARCH, 2020, 80 (11) : 20 - 20
  • [7] The Immune Response to the fVIII Gene Therapy in Preclinical Models
    Patel, Seema R.
    Lundgren, Taran S.
    Spencer, H. Trent
    Doering, Christopher B.
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] The efficacy of BTK inhibitor in IVLBCL preclinical mouse models.
    Takai, Mika
    Shimada, Kazuyuki
    Kiyoi, Hitoshi
    [J]. CANCER SCIENCE, 2023, 114 : 292 - 292
  • [9] The Preclinical Application of the Tactile Discrimination Task in Rat Models.
    Wu, S-H.
    Wen, C-J.
    Huang, J-J.
    Pei, Y-C.
    Lin, C-H.
    Cheng, H.
    Peng, Z-L.
    Yang, H-I.
    Wei, F-C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 757 - 758
  • [10] Genetically engineered models have advantages over xenografts for preclinical studies - Response
    Sausville, EA
    Burger, AM
    [J]. CANCER RESEARCH, 2006, 66 (07) : 3358 - 3359
12345